4.6 Review

Medication overuse headache: Neurobiological, behavioural and therapeutic aspects

Journal

PAIN
Volume 150, Issue 2, Pages 222-224

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/j.pain.2010.05.003

Keywords

-

Funding

  1. Bayer Schering
  2. Biogen
  3. Boehringer Ingelheim
  4. Eisai
  5. Novartis
  6. Lundbeck
  7. Sanofi-Aventis
  8. Sigma-Tau
  9. UCB Pharma
  10. Ricerca Corrente IRCCS
  11. Ricerca Finalizzata IRCCS [European Community]
  12. Italian Minister of Health
  13. AIFA (Agenzia ltaliana del Farmaco)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available